Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Daniel Elliott
Introduction
Daniel Elliott is a notable inventor based in Basel, Switzerland. He has made significant strides in the field of cannabinoid research, holding a total of 4 patents. His work focuses on the applications of cannabinoids for various medical conditions, showcasing his commitment to advancing healthcare solutions.
Latest Patents
Elliott's latest patents include groundbreaking inventions such as "Applications of known and novel cannabinoids." This patent details the use of a medicament as a single agent, binary agent, or other combinations comprising substantially pure novel cannabinoids for the prevention and treatment of inflammatory mediated diseases, cancer, pain, and other chronic medical symptoms. Another significant patent is "Synthetic intermediates for novel cannabinoids and cannabinoid acids and their derivatives." This invention relates to intermediate compounds for synthesizing novel cannabinoids, which can be obtained at high purity levels, thus improving the efficiency of cannabinoid production.
Career Highlights
Elliott's career is marked by his innovative approach to cannabinoid synthesis and application. His work has contributed to the understanding and development of cannabinoid-based treatments, positioning him as a key figure in this emerging field. He is currently associated with Bessor Pharma, LLC, where he continues to explore the potential of cannabinoids in medicine.
Collaborations
Elliott has collaborated with notable professionals in the field, including Barry A Berkowitz and Anthony Gerard Barrett. These partnerships have further enhanced his research and development efforts, leading to advancements in cannabinoid applications.
Conclusion
Daniel Elliott's contributions to cannabinoid research and his innovative patents reflect his dedication to improving medical treatments. His work continues to pave the way for new therapeutic options in the healthcare industry.